Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2026)
Bicycle Therapeutics (BCYC) posted FCF Margin of 7512.74% for Q1 2026, down 17986.02% on a QoQ basis from 41.54% in Q4 2025, and down 664099.0% year-over-year from N/an in Q1 2025.
Bicycle Therapeutics (BCYC) FCF Margin (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' FCF Margin history runs 9 years deep, the most recent figure standing at 7512.74% for Q1 2026.
- Quarterly FCF Margin fell 664099.0% year-over-year to 7512.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 364.89% (up 34288.0% YoY) and the FY2025 annual result came in at 347.21%, up 12326.0% from the prior year.
- FCF Margin was 7512.74% for Q1 2026 at Bicycle Therapeutics, down from 41.54% in the prior quarter.
- Across five years, FCF Margin topped out at 296.74% in Q2 2023 and bottomed at 7512.74% in Q1 2026.
- A 5-year average of 1070.28% and a median of 628.87% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2023 — FCF Margin soared 92560 bps — and 2026, when it tumbled 664099 bps.
- Bicycle Therapeutics' FCF Margin stood at 378.06% in 2022, then plunged by 135 bps to 887.99% in 2023, then jumped by 70 bps to 263.32% in 2024, then soared by 84 bps to 41.54% in 2025, then slumped by 17986 bps to 7512.74% in 2026.
- Business Quant data shows BCYC's FCF Margin at 7512.74% in Q1 2026, 41.54% in Q4 2025, and 612.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -7,512.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,512.74% |
| Dec 31, 2025 | -41.54% |
| Sep 30, 2025 | -612.30% |
| Jun 30, 2025 | -2,509.73% |
| Mar 31, 2025 | -871.75% |
| Dec 31, 2024 | -263.32% |
| Sep 30, 2024 | -1,504.75% |
| Jun 30, 2024 | -481.22% |
| Mar 31, 2024 | -681.55% |
| Dec 31, 2023 | -887.99% |
| Sep 30, 2023 | -28.53% |
| Jun 30, 2023 | 296.74% |
| Mar 31, 2023 | -990.81% |
| Dec 31, 2022 | -378.06% |
| Sep 30, 2022 | -291.28% |
| Jun 30, 2022 | -628.87% |
| Mar 31, 2022 | -807.15% |
| Dec 31, 2021 | -760.44% |
| Sep 30, 2021 | 512.67% |
| Jun 30, 2021 | -702.58% |